Table 2.
Intermediate endpoint | Associated with depression | Associated with CHD outcomes | Improved with exercise | Improved with SSRIs |
---|---|---|---|---|
Heart rate variability | + + + | + + + | + | −/? |
Baroreflex control | + | ++ | + | + |
Flow mediated dilation | + | + + | + + | ? |
Inflammation | + | + ++ | + | ? |
Platelet activity | + | + + + | + | ++ |
−=not related;? = few studies have addressed; + = preliminary evidence; + + = some evidence; + + + = strong evidence.